Northwest Arkansas Pathology adopts Techcyte Fusion for remote signout

By AI, Created 6:46 PM UTC, June 03, 2026, /AGP/ – Northwest Arkansas Pathology Associates has implemented Techcyte Fusion in its lab to support remote pathology workflows and help ease staffing pressure. The move is designed to expand access to specialized expertise while giving pathologists secure remote access to digital slides.

Why it matters: - Pathology groups are under pressure from recruiting and retention challenges, especially when subspecialty expertise is hard to find locally. - Remote signout can help labs keep cases moving without requiring every pathologist to be physically onsite. - Digital workflows can expand access to expertise and give labs more flexibility in how they staff and route cases.

What happened: - Techcyte said Northwest Arkansas Pathology Associates, PA (NWAPath) implemented the Techcyte Fusion platform in its laboratory. - The deployment enables remote pathology workflows built to address staffing challenges and improve access to specialized expertise. - NWAPath can now support remote signout, allowing pathologists to securely access and diagnose digital slides outside the physical lab. - Techcyte announced the deployment on June 4, 2026.

The details: - Techcyte Fusion is a unified digital pathology platform designed to streamline pathology workflows, support collaboration, and integrate with laboratory systems. - The platform uses digitization and AI-based workflow tools to improve operational efficiency and flexibility. - Techcyte Fusion AP includes an ultrafast slide viewer built to support distributed workflows. - NWAPath chose Fusion after evaluating top image management platforms. - The group cited the viewer speed, simplicity, worklist flexibility, EHR data integration, and LIS integration as key reasons for selecting the platform. - NWAPath also reviewed diagnostic solutions from multiple AI vendors. - The group said it was impressed with Fusion’s deep integration of third-party AI solutions in the slide viewer. - Techcyte Fusion supports use cases across anatomic and clinical pathology.

Between the lines: - The adoption suggests digital pathology is shifting from a convenience feature to an operational necessity for some labs. - Techcyte is positioning Fusion as a workflow hub, not just a slide viewer, by emphasizing interoperability with lab systems and AI tools. - NWAPath’s emphasis on flexibility and integration signals that workflow fit may matter as much as diagnostic capability when labs choose platforms. - The move also points to a broader industry effort to modernize pathology practice around distributed expertise.

What’s next: - NWAPath is likely to use the digital workflow to cover immediate staffing gaps while building toward longer-term operational changes. - Techcyte is expected to continue promoting Fusion as a platform for laboratories that want more flexible pathology models. - The company says Fusion is intended to support modernization across anatomic and clinical pathology workflows.

The bottom line: - NWAPath is using Techcyte Fusion to make pathology work more remote, more flexible and less dependent on local staffing depth.